North America Swine Healthcare Market size is valued at USD million in 2021 and is expected to reach USD  million by 2028, at a CAGR of % during the forecast period 2022-2028. Swine are domestic animals adopted for the production of meat. Swine healthcare is related to the diagnosis, prevention, and control of swine disease to make the swine healthy. North America Swine Healthcare Market becomes an essential part of the swine industry for the production of healthy meat and improves the animal husbandry. Most common diseases occur in the swine include food-borne diseases, parasitic diseases, infectious diseases, and nutritional disorders among others. Vaccines are administered to the swine for the prevention of various diseases. Drivers are Increase in the demand for healthy pork meat coupled with rise in number of pork meat industries, Rise in prevalence of various infectious and foodborne diseases and Increase in the R&D activities for the innovation of novel therapeutics and feed products. Restraints are Stringent regulatory guidelines for the swine vaccines and drug approvals and Adverse effects associated with the drugs. In August 2016, Merck Animal Health introduced Safe-Guard Aquasol (fenbendazole oral suspension) for the treatment of parasitic infections in swine.